HEBEI YANDA LU DAOPEI HOSPITAL

BMT Doctors

Yue Lu

Haematologist /Clinical Professor

Clinical focus

Leukaemia, multiple myeloma, lymphoma, aplastic anaemia, thrombocytopenia.

Autoimmune blood diseases.

Benign and malignant haematological and genetic disorders.

HSCT, HSCT complications (GVHD, infection, etc.).

Board Certification

Chinese Board of Internal Medicine

Education and training

Visiting Fellow, Fred Hutchinson Cancer Research Center (2016)

MD, Xiangya School of Medicine, Central South University (2004)

Professional Experience

Clinical Professor, HSCT Department, Lu Daopei Hospital (2004-present)

Accomplishments

Completed over 400 HSCT cases

Professional Publications

Published articles on HSCT in peer-reviewed journals in China

Delivered lectures at domestic and international medical conferences.

1、Effect of NCCN （2015） risk stratification on prognosis of patients with acute myeioid leukemia after allogeneic hematopoietic stem cell transplantation

Lu Yue, Wu Tong, Zhao Yanli, Cao Xingyu, Liu Deyan, Zhang Jianping, Xiong Min, Zhou Jiarui, Sun Ruijuan, Wei Zhijie, Wang Hui, Liu Hongxing, Wang Tong, Tong Chunrong, Ji Shuquan, Lu Daopei.(2017).Effect of NCCN （2015） risk stratification on prognosis of patients with acute myeioid leukemia after allogeneic hematopoietic stem cell transplantation.Chinese Journal of Hematology,38（01）：4449.

2、Effect of minimal residual disease monitoring by multiparameter flow cytometry preconditioning on prognosis of acute myeloid leukemia after allogeneic hematopoietic stem cell transplantation

Lu Yue, Wu Tong, Wang Hui, Zhao Yanli, Cao Xingyu, Liu Deyan, Zhang Jianping, Xiong Min, Zhou Jiarui, Sun Ruijuan, Wei Zhijie, Ji Shuquan, Lu Daopei,(2017).Effect of minimal residual disease monitoring by multiparameter flow cytometry preconditioning on prognosis of acute myeloid leukemia after allogeneic hematopoietic stem cell transplantation.Chinese Journal of Hematology,38（02）：118123.

3、Comparison of three different types of donor hematopoietic stem cell transplantation forintermediate and highrisk myelodysplastic syndrome

Lu Yue, Wu Tong, Zhao Yanli, Cao Xingyu, Liu Deyan, Xiong Min, Zhou Jiarui, Zhang Jianping, Wei Zho＇ie, Sun Ruij＇uan, Lu Daopei.(2017).Comparison of three different types of donor hematopoietic stem cell transplantation forintermediate and highrisk myelodysplastic syndrome. Chinese Journal of Hematology，38（042）：301306.

4、12 cases analysis of Allogeneic hematopoietic stem cell transplantation with myeloablative dose preconditioning in more than 55years old of highrisk malignant Hematologic patients

Lu Yue,et al.(2016).12 cases analysis of Allogeneic hematopoietic stem cell transplantation with myeloablative dose preconditioning in more than 55years old of highrisk malignant Hematologic patients. Chinese Journal of Hematology，37（08）：708711

5、HLAhaploidentical donor hematopoietic transplantation for severe aplastic anemia achieved comparable outcomes with HLAunrelated donor transplantation

Lu Yue, Wu Tong, Cao Xingyu, Zhao Yanli, Liu Deyan, Sun Ruijuan, Xiong Min, Wei Zho＇ie, Zhang Jianping, Zhou Jiarui, Lu Daopei.(2016).HLAhaploidentical donor hematopoietic transplantation for severe aplastic anemia achieved comparable outcomes with HLAunrelated donor transplantation. Chinese Journal of Hematology,37（01）:3538

6、Effects of allogeneic hematopoietic stem cell transplantation on 60 patients with myelodysplastic syndrome

LU Yue, WU Tong, CAO Xingyu, WANG Jingbo, YIN Yuming, LU Daopei.(2010).Effects of allogeneic hematopoietic stem cell transplantation on 60 patients with myelodysplastic syndrome.Chinese Journal of Internal Medicine,49(3):200203.

7、Significant reduction of morbidity and mortality of early CMV disease after allogeneic hematopoietic cell transplantation by preemptive therapy with antiviral drugs and CMV cytotoxic T lymphocytes

LU Yue WU Tong CAO Xingyu WANG Jingbo SUN Yuan ZHAO Yanli DA Wanming JI Shuquan TONG Chunrong ZHANG Longji LU Daopei.(2011).Significant reduction of morbidity and mortality of early CMV disease after allogeneic hematopoietic cell transplantation by preemptive therapy with antiviral drugs and CMV cytotoxic T lymphocytes.Journal of Clinical Hematology, 24(11):655661.

8、Tuberculous infections following allogeneic hematopoietic stem cell transplantation

LU Yue,WU Tong,CAO Xingyu ,WEI Linyi, ZHOU Jiarui ,LU Daopei.(2011).Tuberculous infections following allogeneic hematopoietic stem cell transplantation. Journal of Clinical Hematology,24(7): 391393.

9、Monitoring of early EpsteinBarr virus reactivation and preemptive therapy after allogeneic hematopoietic stem cell transplantation

LU Yue, WU Tong, CAO Xingyu, WANG Jingbo, SUN Yuan, ZHAO Yanli, DA Wanming, JI Shuquan, TONG Chunrong, LU Daopei.(2011).Monitoring of early EpsteinBarr virus reactivation and preemptive therapy after allogeneic hematopoietic stem cell transplantation.Chinese Journal of Internal Medicine, 50(5):383387.

10、 one case report of Non consanguineous peripheral blood hematopoietic stem cell transplantation for T cell large granular lymphoblastic leukemia and pure red cell aplastic anemia

Lu Yue，et al.(2010). one case report of Non consanguineous peripheral blood hematopoietic stem cell transplantation for T cell large granular lymphoblastic leukemia and pure red cell aplastic anemia. National Medical Journal of China,90(4):287288.

participated in editing books：

participated in editing the new version of academician Lu Daopei“Leukemia therapeutics”, editing the chapter of “Allogeneic hematopoietic stem cell transplantation for myelodysplastic syndrome”